Frank Liu
Nuclear Medicine · Washington, DCNPI 1982705331
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,058 of the $1,349 with a category attached, or 78.4%. Novartis accounts for 65.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $911 and has fallen 94.2% since, to $53 in 2025.
Across 12 payments — averaging $112.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$882
- Progenics Pharmaceuticals, Inc.$157
- Advanced Accelerator Applications$110
- Blue Earth Diagnostics$95
- GE HealthCare$61
- Life Molecular Imaging Ltd$24
- plus $21 from 1 others
Across 8 payments — averaging $143,482 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$1.1M
What the payments were for
- Travel & lodging$29222%
- Food & beverage$1,05878%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 4 | $882 |
| Progenics Pharmaceuticals, Inc. | 2 | $157 |
| Advanced Accelerator Applications | 1 | $110 |
| Blue Earth Diagnostics | 1 | $95 |
| GE HealthCare | 2 | $61 |
| Life Molecular Imaging Ltd | 1 | $24 |
| Cardinal Health 414 LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lutathera$110
How this compares
Too few nuclear medicine providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Other nuclear medicine in Washington
- Giuseppe EspositoWashington$414K
- Douglas VannostrandWashington$150K
- Carlos GarciaWashington$983
- Feng XuWashington$142
- Elmo AcioWashington$63
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.